Tower Research Capital (TRC)’s Qualigen Therapeutics QLGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.06K | Buy |
1,188
+814
| +218% | +$2.78K | ﹤0.01% | 4387 |
|
|
2025
Q1 | $1.36K | Sell |
374
-1,058
| -74% | -$3.85K | ﹤0.01% | 4725 |
|
|
2024
Q4 | $6.03K | Buy |
+1,432
| New | +$6.03K | ﹤0.01% | 4213 |
|
|
2024
Q3 | – | Sell |
-121
| Closed | -$1.04K | – | 5929 |
|
|
2024
Q2 | $1.04K | Sell |
121
-1
| -0.8% | -$9 | ﹤0.01% | 5220 |
|
|
2024
Q1 | $2.44K | Buy |
122
+17
| +16% | +$339 | ﹤0.01% | 5039 |
|
|
2023
Q4 | $2.89K | Buy |
105
+6
| +6% | +$165 | ﹤0.01% | 5152 |
|
|
2023
Q3 | $5.01K | Buy |
99
+7
| +8% | +$354 | ﹤0.01% | 4778 |
|
|
2023
Q2 | $4.2K | Buy |
92
+52
| +130% | +$2.37K | ﹤0.01% | 4951 |
|
|
2023
Q1 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 5391 |
|
|
2022
Q4 | – | Sell |
-27
| Closed | -$4K | – | 6272 |
|
|
2022
Q3 | $4K | Buy |
27
+9
| +50% | +$1.33K | ﹤0.01% | 5285 |
|
|
2022
Q2 | $5K | Sell |
18
-9
| -33% | -$2.5K | ﹤0.01% | 5087 |
|
|
2022
Q1 | $9K | Buy |
+27
| New | +$9K | ﹤0.01% | 4480 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6488 |
|
|
2021
Q1 | – | Sell |
-7
| Closed | -$11K | – | 5655 |
|
|
2020
Q4 | $11K | Buy |
+7
| New | +$11K | ﹤0.01% | 4253 |
|
|
2016
Q3 | – | Hold |
0
| – | -$1K | – | 4277 |
|
|
2016
Q2 | – | Hold |
0
| – | -$1K | – | 4198 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3755 |
|
|
2015
Q4 | – | Hold |
0
| – | -$20K | – | 4952 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1733 |
|